Debate : Open radical prostatectomy vs. laparoscopic vs. roboticNELSON, Joel B.Urologic oncology. 2007, Vol 25, Num 6, pp 490-493, issn 1078-1439, 4 p.Conference Paper

Multimodal analgesic approach incorporating paravertebral blocks for open radical retropubic prostatectomy: a randomized double-blind placebo-controlled studyCHELLY, Jacques E; PLOSKANYCH, Taras; FENG DAI et al.Canadian journal of anaesthesia. 2011, Vol 58, Num 4, pp 371-378, issn 0832-610X, 8 p.Article

Delayed intraoperative hydration limits blood loss during radical retropubic prostatectomyDAVIES, Benjamin J; CHUNG, Steve Y; NELSON, Joel B et al.Urology (Ridgewood, NJ). 2004, Vol 64, Num 4, pp 712-716, issn 0090-4295, 5 p.Article

Comparative Hospital Cost-analysis of Open and Robotic-assisted Radical ProstatectomyTOMASZEWSKI, Jeffrey J; MATCHETT, Jarred C; DAVIES, Benjamin J et al.Urology (Ridgewood, NJ). 2012, Vol 80, Num 1, pp 126-129, issn 0090-4295, 4 p.Article

Phase 3, Randomized, Placebo-Controlled Study of Zibotentan (ZD4054) in Patients With Castration-Resistant Prostate Cancer Metastatic to BoneNELSON, Joel B; FIZAZI, Karim; MILLER, Kurt et al.Cancer. 2012, Vol 118, Num 22, pp 5709-5718, issn 0008-543X, 10 p.Article

Intraoperative cell salvage in radical prostatectomy does not appear to increase long-term biochemical recurrence, metastases, or mortalityRAVAL, Jay S; NELSON, Joel B; WOLDEMICHAEL, Elen et al.Transfusion (Philadelphia, PA). 2012, Vol 52, Num 12, pp 2590-2593, issn 0041-1132, 4 p.Article

Prolongation of Off-Cycle Interval by Finasteride Is Not Associated With Survival Improvement in Intermittent Androgen DeprivationTherapy in LNCaP Tumor ModelYUJUAN WANG; GUPTA, Shubham; VI HUA et al.The Prostate. 2010, Vol 70, Num 2, pp 147-154, issn 0270-4137, 8 p.Article

Phase 3, Randomized, Controlled Trial of Atrasentan in Patients With Nonmetastatic, Hormone-Refractory Prostate CancerNELSON, Joel B; LOVE, William; CHIN, Joseph L et al.Cancer. 2008, Vol 113, Num 9, pp 2478-2487, issn 0008-543X, 10 p.Article

Caspase-dependent apoptosis induction by phenethyl isothiocyanate, a cruciferous vegetable - derived cancer chemopreventive agent, is mediated by Bak and BaxDONG XIAO; YAN ZENG; SUNGA CHOI et al.Clinical cancer research. 2005, Vol 11, Num 7, pp 2670-2679, issn 1078-0432, 10 p.Article

Function and survival of dendritic cells depend on endothelin-1 and endothelin receptor autocrine loopsGURULI, Georgi; PFLUG, Beth R; PECHER, Stefana et al.Blood. 2004, Vol 104, Num 7, pp 2107-2115, issn 0006-4971, 9 p.Article

Nonandrogenic mediators of prostatic growthKONETY, Badrinath R; NELSON, Joel B.Hematology/oncology clinics of North America. 2001, Vol 15, Num 3, issn 0889-8588, vi, 459-476 [19 p.]Article

5α-Reductase Inhibition Suppresses Testosterone-Induced Initial Regrowth of Regressed Xenograft Prostate Tumors in Animal ModelsMASOODI, Khalid Z; RAMOS GARCIA, Raquel; NELSON, Joel B et al.Endocrinology (Philadelphia). 2013, Vol 154, Num 7, pp 2296-2307, issn 0013-7227, 12 p.Article

Future therapies in hormone-refactory protate cacer. DiscussionSMITH, Matthew R; NELSON, Joel B; DIPAOLA, Robert S et al.SMITH, Matthew R; NELSON, Joel B; Urology (Ridgewood, NJ). 2005, Vol 65, Num 5A, pp 9-17, issn 0090-4295, 9 p., SUPConference Paper

Multidisciplinary management of advanced prostate cancer : Changing perspectives on referring patients and enhancing collaboration between oncologists and urologists in clinical trials. DiscussionCARDUCCI, Michael A; CARROLL, Peter R; SMITH, Matthew R et al.Urology (Ridgewood, NJ). 2005, Vol 65, Num 5A, pp 18-22, issn 0090-4295, 5 p., SUPConference Paper

The role of inflammation in the pathogenesis of prostate cancer. DiscussionNELSON, William G; DE MARZO, Angelo M; DEWEESE, Theodore L et al.The Journal of urology. 2004, Vol 172, Num 5, pp S6-S12, issn 0022-5347, 2Conference Paper

Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: A randomized, phase II, placebo-controlled trialCARDUCCI, Michael A; PADLEY, Robert J; SCHMITT, Jennifer L et al.Journal of clinical oncology. 2003, Vol 21, Num 4, pp 679-689, issn 0732-183X, 11 p.Article

Bicalutamide monotherapy for early stage prostate cancer: An update. DiscussionIVERSEN, Peter; ROACH, Mack III; SMITH, Matthew R et al.The Journal of urology. 2003, Vol 170, Num 6, pp S48-S54, issn 0022-5347, 2Conference Paper

Endothelin inhibition: Novel therapy for prostate cancer. DiscussionNELSON, Joel B; SELLERS, William R; SMITH, Matthew R et al.The Journal of urology. 2003, Vol 170, Num 6, pp S65-S68, issn 0022-5347, 2Conference Paper

Use of expression analysis to predict outcome after radical prostatectomy. DiscussionFEBBO, Phillip G; SELLERS, William R; CARROLL, Peter R et al.The Journal of urology. 2003, Vol 170, Num 6, pp S11-S20, issn 0022-5347, 2Conference Paper

Atrasentan, an endothelin-receptor antagonist for refractory adenocarcinomas: Safety and pharmacokineticsCARDUCCI, Michael A; NELSON, Joel B; JANUS, Todd J et al.Journal of clinical oncology. 2002, Vol 20, Num 8, pp 2171-2180, issn 0732-183XArticle

Chemopreventative Potential of the Cruciferous Vegetable Constituent Phenethyl Isothiocyanate in a Mouse Model of Prostate CancerPOWOLNY, Anna A; BOMMAREDDY, Ajay; HAHM, Eun-Ryeong et al.Journal of the National Cancer Institute. 2011, Vol 103, Num 7, pp 571-584, issn 0027-8874, 14 p.Article

Increased Cancer Cell Proliferation in Prostate Cancer Patients With High Levels of Serum FolateTOMASZEWSKI, Jeffrey J; CUMMINGS, Jessica L; PARWANI, Anil V et al.The Prostate. 2011, Vol 71, Num 12, pp 1287-1293, issn 0270-4137, 7 p.Article

Body composition changes during androgen deprivation therapy for prostate cancer : A 2-year prospective studyVAN LONDEN, Gijsberta J; LEVY, Matthew E; PERERA, Subashan et al.Critical reviews in oncology/hematology. 2008, Vol 68, Num 2, pp 172-177, issn 1040-8428, 6 p.Article

Therapeutic Effects of Endothelin-A Receptor Antagonist on Bladder Overactivity in Rats with Chronic Spinal Cord InjuryOGAWA, Teruyuki; SASATOMI, Kurumi; HIRAGATA, Shiro et al.Urology (Ridgewood, NJ). 2008, Vol 71, Num 2, pp 341-345, issn 0090-4295, 5 p.Article

Page / 2